Quarterly report pursuant to Section 13 or 15(d)

9. RELATED PARTY TRANSACTIONS (Details)

v3.8.0.1
9. RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Sale and purchase of plasma          
Product revenue $ 2,808,640 $ 2,267,051 $ 7,262,915 $ 6,107,240  
Purchases 1,411,500 326,820 1,735,640 1,215,075  
License revenue 35,708 35,708 107,125 107,125  
Interest expense 230,000 $ 0 290,000 $ 0  
Accounts receivable 876,551   876,551   $ 969,675
Prepaid expenses and other current assets 91,222   91,222   0
Accounts payable 1,393,667   1,393,667   82,427
Accrued expenses 222,671   222,671   0
Note payable, net of discount 14,834,696   14,834,696   0
Accrued interest 290,000   290,000   0
Deferred revenue $ 2,725,741   $ 2,725,741   $ 2,832,867